| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
205: ABT-335 in Combination with Rosuvastatin Improves Multiple Lipid Ratios in Patients with Mixed Dyslipidemia
|
Davidson, Michael H.
|
|
2008
|
2 |
3 |
p. 211-212
2 p.
|
artikel
|
| 2 |
204: Aspirin Use Prior to Initiation of Therapy with a Proprietary Niacin Extended-Release Reduces Discontinuation Rates Due to Flushing
|
Brinton, Eliot A.
|
|
2008
|
2 |
3 |
p. 211-
1 p.
|
artikel
|
| 3 |
210: Blood Cell Fatty Acid Profiles Discriminate Acute Coronary Syndrome Case Status Better than Standard Cardiovascular Risk Factors
|
Harris, William S.
|
|
2008
|
2 |
3 |
p. 214-217
4 p.
|
artikel
|
| 4 |
209: Cardiovascular Risk Profile in First Generation Southeast Asian Children and Adolescents: Comparison between Caucasian and Southeast Asian Students in the Wausau SCHOOL Project
|
Hanlin, Erin R.
|
|
2008
|
2 |
3 |
p. 214-
1 p.
|
artikel
|
| 5 |
220: CDC's Lipid Standardization Program: Assuring Quality in Epidemiologic Studies for 50 Years
|
Kimberly, Mary M.
|
|
2008
|
2 |
3 |
p. 222-
1 p.
|
artikel
|
| 6 |
103: Changes in Core Temperature Are Related to Free Fatty Acid Rebound from Niacin
|
Gadi, Ramprasad
|
|
2008
|
2 |
3 |
p. 203-
1 p.
|
artikel
|
| 7 |
306: Colesevelam HCl in Type 2 Diabetes Reduces A1C and LDL-C Consistently Across Age, Gender, and Race
|
Jones, Michael Roe
|
|
2008
|
2 |
3 |
p. 229-230
2 p.
|
artikel
|
| 8 |
107: Combination Thiazolidinedione (TZD) and Fibrate Effect on High Density Lipoprotein Concentration (HDL-C)
|
Russell, Nicole M.
|
|
2008
|
2 |
3 |
p. 205-
1 p.
|
artikel
|
| 9 |
Coronary heart disease risk factors and atherosclerosis in young people
|
McMahan, C. Alex
|
|
2008
|
2 |
3 |
p. 118-126
9 p.
|
artikel
|
| 10 |
203: Discontinuation Rate Due to Flushing Is Less than 6% Following Therapy with a Proprietary Niacin Extended-Release
|
Brinton, Eliot A.
|
|
2008
|
2 |
3 |
p. 210-211
2 p.
|
artikel
|
| 11 |
202: Dual Efficacy: A1C and LDL-C Lowering with Colesevelam HCl in Patients with Type 2 Diabetes Mellitus
|
Bays, Harold Edward
|
|
2008
|
2 |
3 |
p. 210-
1 p.
|
artikel
|
| 12 |
Editorial board
|
|
|
2008
|
2 |
3 |
p. A3-A4
nvt p.
|
artikel
|
| 13 |
104: Effect of a Muscadine Grapeseed Supplement on Endothelial Function: A Randomized Crossover Trial
|
Mellen, Philip B.
|
|
2008
|
2 |
3 |
p. 203-204
2 p.
|
artikel
|
| 14 |
223: Effect of Weight Loss on Cardiometabolic Risk Using a Structured Dietary Program
|
Robledo, Melissa J.
|
|
2008
|
2 |
3 |
p. 223-224
2 p.
|
artikel
|
| 15 |
215: Effects of ABT-335 in Combination with Rosuvastatin on Low-Density Lipoprotein Particle Size in Patients with Mixed Dyslipidemia
|
Jones, Peter H.
|
|
2008
|
2 |
3 |
p. 219-220
2 p.
|
artikel
|
| 16 |
100: Effects of Atazanavir/Ritonavir or Fosamprenavir/Ritonavir on the Pharmacokinetics of Rosuvastatin
|
Bain, Amy
|
|
2008
|
2 |
3 |
p. 202-
1 p.
|
artikel
|
| 17 |
224: Effects of Colesevelam HCL on Lipoprotein Subclasses in Subjects with Type 2 Diabetes
|
Rosenson, Robert S.
|
|
2008
|
2 |
3 |
p. 224-
1 p.
|
artikel
|
| 18 |
217: Effects of Niacin Extended-Release/Simvastatin Versus Simvastatin Monotherapy on Plasma Lipids in Patients with or without High Baseline Triglycerides
|
Karas, Richard H.
|
|
2008
|
2 |
3 |
p. 220-221
2 p.
|
artikel
|
| 19 |
221: Effects of Prescription Omega-3-Acid Ethyl Esters Plus Simvastatin on Lipids and Lipoprotein Particles in Mixed Dyslipidemia
|
Maki, Kevin Carl
|
|
2008
|
2 |
3 |
p. 222-223
2 p.
|
artikel
|
| 20 |
214: Efficacy and Safety of ABT-335 (Fenofibric Acid) in Combination with Rosuvastatin in Patients with Mixed Dyslipidemia: A Phase 3 Study
|
Jones, Peter H.
|
|
2008
|
2 |
3 |
p. 218-219
2 p.
|
artikel
|
| 21 |
106: Efficacy and Safety of Multi-drug Therapy for Hypertriglceridemia
|
Polsani, Venkat
|
|
2008
|
2 |
3 |
p. 204-205
2 p.
|
artikel
|
| 22 |
Elevated atherogenic lipoproteins in childhood: Risk, prevention, and treatment
|
McCrindle, Brian W.
|
|
2008
|
2 |
3 |
p. 138-146
9 p.
|
artikel
|
| 23 |
Exercise—Promoting healthy lifestyles in children and adolescents
|
Trost, Stewart G.
|
|
2008
|
2 |
3 |
p. 162-168
7 p.
|
artikel
|
| 24 |
From the Editor-in-Chief
|
Brown, W. Virgil
|
|
2008
|
2 |
3 |
p. 113-
1 p.
|
artikel
|
| 25 |
Getting the word out: Teaching middle-school children about cardiovascular disease
|
Toepperwein, Mary Anne
|
|
2008
|
2 |
3 |
p. 179-188
10 p.
|
artikel
|
| 26 |
302: Glycemic Effect of Extended-Release Niacin Plus Statin versus Other Lipid Therapies in Managed Care Dyslipidemia Patients with Type 2 Diabetes
|
Burge, Russel
|
|
2008
|
2 |
3 |
p. 227-
1 p.
|
artikel
|
| 27 |
225: Implementation of a Coronary Artery Calcium Scoring-Based Lipid Management Program in a University Medical Center: The EDUCATE Program
|
Orringer, Carl E.
|
|
2008
|
2 |
3 |
p. 224-225
2 p.
|
artikel
|
| 28 |
216: Incidence of Flushing Decreases Over Time During Long-Term Therapy with a Novel Combination of Niacin Extended-Release with Simvastatin
|
Karas, Richard H.
|
|
2008
|
2 |
3 |
p. 220-
1 p.
|
artikel
|
| 29 |
102: Initial Results of a Home Patient Screening Kit for Diabetes and Dyslipidemia
|
Borden, William B.
|
|
2008
|
2 |
3 |
p. 202-203
2 p.
|
artikel
|
| 30 |
108: Is Obesity an Independent Predictor of Post-operative Renal Insufficiency?
|
Virani, Salim S.
|
|
2008
|
2 |
3 |
p. 205-206
2 p.
|
artikel
|
| 31 |
208: Lipid Disorder Classification
|
Feeman, W.E.
|
|
2008
|
2 |
3 |
p. 213-214
2 p.
|
artikel
|
| 32 |
Lipid metabolism in children and adolescents: Impact on vascular biology
|
Mietus-Snyder, Michele
|
|
2008
|
2 |
3 |
p. 127-137
11 p.
|
artikel
|
| 33 |
303: Lipid Therapy Utilization Rates in a Mixed Dyslipidemia Managed Care Population
|
Burge, Russel
|
|
2008
|
2 |
3 |
p. 228-
1 p.
|
artikel
|
| 34 |
222: Lipoproteins in the Prediction of Coronary Artery Calcium (CAC) as Modified by Age in the Multi-Ethnic Study of Atherosclerosis (MESA)
|
Paramsothy, Pathmaja
|
|
2008
|
2 |
3 |
p. 223-
1 p.
|
artikel
|
| 35 |
206: Long-Term Use of Colesevelam HCl Improves LDL-C and HDL-C Concentrations in Subjects with Primary Hypercholesterolemia
|
Davidson, Michael H.
|
|
2008
|
2 |
3 |
p. 212-213
2 p.
|
artikel
|
| 36 |
211: Low-Density Lipoprotein Cholesterol Lowering by High-Efficacy Statins: Are Older Women at an Advantage?
|
Insull, William
|
|
2008
|
2 |
3 |
p. 217-
1 p.
|
artikel
|
| 37 |
Metabolic syndrome and dyslipidemia in youth
|
McNeal, Catherine
|
|
2008
|
2 |
3 |
p. 147-155
9 p.
|
artikel
|
| 38 |
News from the National Lipid Association
|
|
|
2008
|
2 |
3 |
p. 114-116
3 p.
|
artikel
|
| 39 |
218: Niacin Extended-Release/Simvastatin Results in Attainment of Optimal Lipid Levels in Patients Who Failed to Attain These Levels on Statin Monotherapy
|
Karas, Richard H.
|
|
2008
|
2 |
3 |
p. 221-
1 p.
|
artikel
|
| 40 |
Overview: Pediatric lipid disorders
|
McNeal, Catherine
|
|
2008
|
2 |
3 |
p. 117-
1 p.
|
artikel
|
| 41 |
Pediatric dyslipidemias: Prescription medication efficacy and safety
|
Browne, Barry
|
|
2008
|
2 |
3 |
p. 189-201
13 p.
|
artikel
|
| 42 |
200: Physical Conditions That Can Trigger Cholesterol Crystallization Leading to Plaque Rupture
|
Abela, George S.
|
|
2008
|
2 |
3 |
p. 207-208
2 p.
|
artikel
|
| 43 |
Promoting healthy lifestyles: Behavior modification and motivational interviewing in the treatment of childhood obesity
|
Limbers, Christine A.
|
|
2008
|
2 |
3 |
p. 169-178
10 p.
|
artikel
|
| 44 |
105: Raised Triglycerides Is an Independent Predictor of Diabetes in Patients With Non-genotype 3 Chronic Hepatitis C Infection
|
Nachnani, Jagdish S.
|
|
2008
|
2 |
3 |
p. 204-
1 p.
|
artikel
|
| 45 |
305: Response to Colesevelam HCl in Patients with Type 2 Diabetes
|
Jones, Michael Roe
|
|
2008
|
2 |
3 |
p. 229-
1 p.
|
artikel
|
| 46 |
304: Retrospective Analysis of Treatment for Mixed Dyslipidemic Patients
|
Hume, Andrea R.
|
|
2008
|
2 |
3 |
p. 228-229
2 p.
|
artikel
|
| 47 |
213: Short-Term Treatment with Ezetimibe Does Not Reduce Plasminogen Activator Inhibitor-1 Compared to Simvastatin
|
Ito, Matthew Katsutoshi
|
|
2008
|
2 |
3 |
p. 218-
1 p.
|
artikel
|
| 48 |
201: Simple Programming of the GE-Centricity Electronic Medical Record Facilitates Disease Management of Hyperlipidemia
|
Aspry, Karen E.
|
|
2008
|
2 |
3 |
p. 208-209
2 p.
|
artikel
|
| 49 |
Societal aspects in the dietary management of childhood hyperlipidemia
|
Walzem, Rosemary L.
|
|
2008
|
2 |
3 |
p. 156-161
6 p.
|
artikel
|
| 50 |
212: Statins Work Best in Those Who Need Them Most: Greater HDL-C Increase and Greater TG Reduction in Patients with Low HDL-C and/or High TG
|
Insull, William
|
|
2008
|
2 |
3 |
p. 217-218
2 p.
|
artikel
|
| 51 |
Table of contents
|
|
|
2008
|
2 |
3 |
p. A7-
1 p.
|
artikel
|
| 52 |
207: The Best Lipid Predictor
|
Feeman, W.E.
|
|
2008
|
2 |
3 |
p. 213-
1 p.
|
artikel
|
| 53 |
219: The Combination of Niacin Extended-Release with Simvastatin Improves Lipid Levels in Treatment-Naive Patients
|
Karas, Richard H.
|
|
2008
|
2 |
3 |
p. 221-222
2 p.
|
artikel
|
| 54 |
301: The Effectiveness of an Independent Nurse Practitioner and Dietitian Owned Lipid Clinic in Achieving Treatment Goals in Refractory Patients
|
Algozzine, Thomas
|
|
2008
|
2 |
3 |
p. 226-227
2 p.
|
artikel
|
| 55 |
300: The Use of Colesevelam HCl with Concomitant Statin Therapy in Type 2 Diabetes Mellitus Improves Glycemic Control and the Lipid Profile
|
Abby, Stacey Lynn
|
|
2008
|
2 |
3 |
p. 226-
1 p.
|
artikel
|
Tijdschrift beschrijving